COMMON BRAND NAME(S): Viracept
GENERIC NAME(S): NELFINAVIR MESYLATE
Description: Nelfinavir is a selective, competitive, reversible HIV protease inhibitor. It inhibits HIV-1 protease resulting in the production of noninfectious virus.
Pharmacokinetics:
Absorption: Absorbed from the GI tract. Peak plasma levels in 2-4 hr. Absorption increased with food.
Distribution: Extensively bound to plasma proteins (98%). Enters breast milk.
Metabolism: Hepatic via oxidation.
Excretion: Mainly via faeces (as metabolites); via urine (about 1-2%). Terminal half-life: 3.5-5 hr.